Pharmacokinetic evaluation of piperacillin-tazobactam

Expert Opinion on Drug Metabolism & Toxicology
Yoshiro HayashiJeffrey Lipman

Abstract

Piperacillin-tazobactam is a frequently prescribed intravenous antibiotic for moderate to severe infections used in hospital settings because of its broad activity against many pathogenic bacteria including Pseudomonas aeruginosa. However, its pharmacokinetics (PK) can be significantly altered in a variety of states. This article provides a comprehensive and critical review of the PK of piperacillin-tazobactam in different patient populations. The pharmacodynamics (PD) of piperacillin-tazobactam is also discussed. The importance of appropriate antibiotic dosing in the context of the global tendency for reduced susceptibility of bacteria, including P. aeruginosa is emphasized. The interrelationship between PK and PD is discussed to provide an understanding of methods for procuring dosing regimens that increase the likelihood of clinical success for individual patients. Alternative dosing regimens, which may include administration by extended or continuous infusion of piperacillin-tazobactam as a mechanism to increase the likelihood of pharmacodynamic target attainment, are described. Where piperacillin-tazobactam is required for treatment, applying knowledge of PK and PD characteristics can facilitate optimal outcomes.

References

Dec 1, 1978·Antimicrobial Agents and Chemotherapy·T B TjandramagaL Verbist
Jan 1, 1992·Clinical Pharmacology and Therapeutics·C A JohnsonD S Greene
Jun 1, 1991·Antimicrobial Agents and Chemotherapy·R WiseJ M Andrews
Jan 1, 1982·Chemotherapy·T Bergan, J D Williams
Jan 1, 1983·European Journal of Clinical Pharmacology·G R AronoffF C Luft
Dec 1, 1994·Antimicrobial Agents and Chemotherapy·M D ReedJ L Blumer
Jul 1, 1994·Intensive Care Medicine·F Sörgel, M Kinzig
Apr 1, 1994·Antimicrobial Agents and Chemotherapy·S J IncavoF Sörgel
Jan 1, 1993·The Journal of Antimicrobial Chemotherapy·F Sörgel, M Kinzig
Jan 1, 1993·The Journal of Antimicrobial Chemotherapy·D M Livermore
May 1, 1997·Antimicrobial Agents and Chemotherapy·R NauH W Prange
Aug 1, 1997·Antimicrobial Agents and Chemotherapy·J F WestphalF Jehl
Feb 10, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·W A Craig
Mar 3, 1998·European Journal of Obstetrics, Gynecology, and Reproductive Biology·P BourgetP Van Peborgh
Aug 2, 2001·The Journal of Antimicrobial Chemotherapy·M K KimD P Nicolau
Sep 21, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A Del FaveroUNKNOWN Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Infection Program
Feb 19, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Walter T HughesLowell S Young
May 17, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Donald R GrahamRichard Gesser
Jun 20, 2003·British Journal of Clinical Pharmacology·Florian TomaselliFreyja M Smolle-Jüttner
Oct 9, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Benjamin A LipskyUNKNOWN Infectious Diseases Society of America
Jan 25, 2005·International Journal of Antimicrobial Agents·Helio S Sader, Ronald N Jones
Feb 9, 2005·American Journal of Respiratory and Critical Care Medicine·UNKNOWN American Thoracic Society, UNKNOWN Infectious Diseases Society of America
Oct 19, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Dennis L StevensUNKNOWN Infectious Diseases Society of America
Nov 26, 2005·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·T R FritscheR N Jones
Apr 22, 2006·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Arturo S Dela PenaUNKNOWN Optimizing Intra-Abdominal Surgery with Invanz (OASIS)-I Study Group

❮ Previous
Next ❯

Citations

Sep 18, 2013·International Journal of Antimicrobial Agents·Syamhanin AdnanJason A Roberts
Dec 14, 2011·Critical Care : the Official Journal of the Critical Care Forum·Leonardo PaganiStephan Harbarth
Jun 24, 2014·Nutrition & Diabetes·M HitesF Jacobs
Jan 1, 2012·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·David R Snydman
Nov 7, 2016·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·H WokseppT Schön
Jun 20, 2017·Expert Opinion on Pharmacotherapy·Kohei TakimotoYoshiro Hayashi
Mar 28, 2018·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Milan KaskaJirina Martinkova
Mar 6, 2018·The Journal of Antimicrobial Chemotherapy·Mahipal G SinnollareddyJason A Roberts
Nov 1, 2016·Antimicrobial Agents and Chemotherapy·Danny TsaiJason A Roberts
Jun 14, 2014·Clinical Pharmacology and Therapeutics·T W FeltonW W Hope
Nov 15, 2019·Journal of Clinical Microbiology·Andrew Henderson, Romney Humphries
May 25, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Paul WhitakerB Kevin Park
Jan 1, 2012·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·David R Snydman
Sep 24, 2016·Infection & chemotherapy·Yong Kyun KimUNKNOWN Pharmacokinetics-Pharmacodynamics of Antibiotics Working Group under Korean Society for Chemotherapy
Mar 27, 2018·The Journal of Antimicrobial Chemotherapy·Ana C Miranda BastosFrançoise Van Bambeke
Mar 24, 2021·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Wenyan LiJing Dong
Apr 21, 2021·Clinical Pharmacokinetics·Ibrahim El-HaffafAmélie Marsot
Apr 22, 2021·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Fabio S TacconeJacques Creteur
Apr 23, 2021·Transplant Infectious Disease : an Official Journal of the Transplantation Society·Dilmurodjon EshmuminovPierre-Alain Clavien
Sep 30, 2020·Current Drug Metabolism·Xuan YuChen Cheng

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
Fiona L M ChewSubrayan Visvaraja
Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns
Dai-zhi PengGuang-xia Xiao
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
L D Liebowitz, K P Klugman
© 2021 Meta ULC. All rights reserved